FDA Inspection
Cayman Chemical Company, Inc.Cayman Chemical Company, Inc. – FDA Inspection, Dec 3, 2018
Record Details
This FDA Inspection record concerns Cayman Chemical Company, Inc., with an inspection on December 3, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
View Company Profile
ID · 3453ef33-da57-46f9-b6c1-2c6519ccd350
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1074100
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Cayman Chemical Company, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 17, 2025 | Not classified | Detroit District Office | |
| November 19, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 28, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 22, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 15, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cayman Chemical Company, Inc.
- FDA Inspection 1267154 - 2025-04-17
- FDA Inspection 904339 - 2014-11-19
- FDA Inspection 820205 - 2013-02-28
- FDA Inspection 759917 - 2011-12-22
- FDA Inspection 701895 - 2010-12-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.